As a sister of the MLL Munich Leukemia Laboratory, we have many years of experience in the comprehensive diagnostics of leukemia and lymphomas. Our strength is our comprehensive diagnostics, which includes the relevant methods cytomorphology, cytogenetics, immunophenotyping and molecular genetics. We analyze more than 85,000 samples annually. Through the synergy of the methods and teams and the interplay of physicians, molecular biologists and bioinformaticians, we can create a comprehensive picture of the disease and give the best possible diagnosis. We invest in research and drive the methodological and diagnostic development forward in order to provide each patient with the best possible diagnosis and thus allow for the opportunity of tailored therapy. MLL Dx thus offers our expertise in leukemia diagnostics also outside the German health care system.
We combine all relevant methods used in the diagnostics of leukemia and lymphoma under one single roof. We are always methodically up-to-date and are continuously setting new standards through further development. Our offered analyses are therefore comprehensive and include not only official recommendations but also scientific findings.
Since 2009 the MLL has been accredited according to the international standards DIN EN ISO 15189 "Medical laboratories - special requirements for quality and competence" and DIN EN ISO/IEC 17025 "General requirements for the competence of testing and calibration laboratories" and have successfully maintained these accreditations since then. In the same way, MLL Dx started quality management according to these two standards soon after its foundation and received this accreditation right away in 2019.